Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjing Bai

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
ACS Nano|February 6, 2026
A Recombinant Targeted Bionanoparticle In Vitro Expressing a Gene-Editing Protein for Epidermal Growth Factor Receptor Mutant Lung CancerYuxin Ren, Jiarui Xu, Qian Luo, et al.
Cellular Signalling|December 18, 2018
TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cellsYan Zhao, Qiaoxi Xia, Yan Liu, et al.
ACS Nano|September 12, 2025
Nanoparticle-Mediated "Cut-Off and Clean-Up" Strategy for Neutrophil Manipulation in Acute Lung Injury TherapyJiaxin Li, Yeyi Hu, Shuang Chen, et al.
Molecular Oncology|September 27, 2023
A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancerQiaoxi Xia, Zepeng Du, Mantong Chen, et al.
Molecular Therapy. Oncology|May 31, 2024
Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8<sup>+</sup> T cell activationWenjing Bai, Xia Tang, Tong Xiao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 26, 2026
Reduced Maintenance DNA Methylation Thresholds Enable Sensitive Reporter Assays for UHRF1 and DNMT1 InhibitionCuicui Xia, Ying Cui, Jiongliang Wang, et al.
Cell Death and Differentiation|January 25, 2018
Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosisQian Sun, Shuzhan Li, Yanan Wang, et al.
Nature Communications|January 8, 2025
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapyWenjing Bai, Jinxin Xu, Wenbin Gu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2026
Identification of YBX1 as an essential host RNA binding protein governing tumor-selective replication of oncolytic virus M1Shanyu Huang, Huizhen Zou, Shiming Yi, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
ACS Nano|February 6, 2026
A Recombinant Targeted Bionanoparticle In Vitro Expressing a Gene-Editing Protein for Epidermal Growth Factor Receptor Mutant Lung CancerYuxin Ren, Jiarui Xu, Qian Luo, et al.
Cellular Signalling|December 18, 2018
TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cellsYan Zhao, Qiaoxi Xia, Yan Liu, et al.
ACS Nano|September 12, 2025
Nanoparticle-Mediated "Cut-Off and Clean-Up" Strategy for Neutrophil Manipulation in Acute Lung Injury TherapyJiaxin Li, Yeyi Hu, Shuang Chen, et al.
Molecular Oncology|September 27, 2023
A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancerQiaoxi Xia, Zepeng Du, Mantong Chen, et al.
Molecular Therapy. Oncology|May 31, 2024
Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8<sup>+</sup> T cell activationWenjing Bai, Xia Tang, Tong Xiao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 26, 2026
Reduced Maintenance DNA Methylation Thresholds Enable Sensitive Reporter Assays for UHRF1 and DNMT1 InhibitionCuicui Xia, Ying Cui, Jiongliang Wang, et al.
Cell Death and Differentiation|January 25, 2018
Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosisQian Sun, Shuzhan Li, Yanan Wang, et al.
Nature Communications|January 8, 2025
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapyWenjing Bai, Jinxin Xu, Wenbin Gu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2026
Identification of YBX1 as an essential host RNA binding protein governing tumor-selective replication of oncolytic virus M1Shanyu Huang, Huizhen Zou, Shiming Yi, et al.
Pageof 5